Increasing doses of b-AP15 significantly inhibited both basal and TNFα-induced NFκB activity even at low doses, as demonstrated using an HPV- UMSCC1 HNSCC reporter cell line previously established in our lab ([13]; Fig. 4B). This evidence concerns the gene NFKB1 and head and neck squamous cell carcinoma.